» Articles » PMID: 34381308

Inflammation and Alzheimer's Disease: Mechanisms and Therapeutic Implications by Natural Products

Overview
Publisher Wiley
Specialties Biochemistry
Pathology
Date 2021 Aug 12
PMID 34381308
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder with no clear causative event making the disease difficult to diagnose and treat. The pathological hallmarks of AD include amyloid plaques, neurofibrillary tangles, and widespread neuronal loss. Amyloid-beta has been extensively studied and targeted to develop an effective disease-modifying therapy, but the success rate in clinical practice is minimal. Recently, neuroinflammation has been focused on as the event in AD progression to be targeted for therapies. Various mechanistic pathways including cytokines and chemokines, complement system, oxidative stress, and cyclooxygenase pathways are linked to neuroinflammation in the AD brain. Many cells including microglia, astrocytes, and oligodendrocytes work together to protect the brain from injury. This review is focused to better understand the AD inflammatory and immunoregulatory processes to develop novel anti-inflammatory drugs to slow down the progression of AD.

Citing Articles

Mechanisms and Emerging Regulators of Neuroinflammation: Exploring New Therapeutic Strategies for Neurological Disorders.

Kim M, Lee J Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852123 PMC: 11763386. DOI: 10.3390/cimb47010008.


Unveiling the multifaceted pathogenesis and therapeutic drugs of Alzheimer's disease: A comprehensive review.

Peng L, Zhang Z, Li Q, Song Z, Yan C, Ling H Heliyon. 2024; 10(20):e39217.

PMID: 39629139 PMC: 11612466. DOI: 10.1016/j.heliyon.2024.e39217.


Navigating Alzheimer's Disease Mouse Models: Age-Related Pathology and Cognitive Deficits.

De Plano L, Saitta A, Oddo S, Caccamo A Biomolecules. 2024; 14(11).

PMID: 39595581 PMC: 11592094. DOI: 10.3390/biom14111405.


Lactocaseibacillus-deglycosylated isoflavones prevent Aβ 40-induced Alzheimer's disease in a rat model.

Liu C, Young Z, Shih T, Pan T, Lee C AMB Express. 2024; 14(1):90.

PMID: 39105988 PMC: 11303605. DOI: 10.1186/s13568-024-01735-y.


Genus : Exploring Its Potential as a Functional Food Ingredient with Neuroprotective Properties Mediated by Antioxidant and Anti-Inflammatory Mechanisms.

Merecz-Sadowska A, Sitarek P, Zajdel K, Sztandera W, Zajdel R Int J Mol Sci. 2024; 25(14).

PMID: 39063085 PMC: 11277136. DOI: 10.3390/ijms25147843.


References
1.
Forni C, Facchiano F, Bartoli M, Pieretti S, Facchiano A, DArcangelo D . Beneficial Role of Phytochemicals on Oxidative Stress and Age-Related Diseases. Biomed Res Int. 2019; 2019:8748253. PMC: 6475554. DOI: 10.1155/2019/8748253. View

2.
Weiner H, Selkoe D . Inflammation and therapeutic vaccination in CNS diseases. Nature. 2002; 420(6917):879-84. DOI: 10.1038/nature01325. View

3.
Franceschi C, Campisi J . Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014; 69 Suppl 1:S4-9. DOI: 10.1093/gerona/glu057. View

4.
Phillips E, Croft C, Kurbatskaya K, ONeill M, Hutton M, Hanger D . Astrocytes and neuroinflammation in Alzheimer's disease. Biochem Soc Trans. 2014; 42(5):1321-5. DOI: 10.1042/BST20140155. View

5.
Nagele R, DAndrea M, Lee H, Venkataraman V, Wang H . Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains. Brain Res. 2003; 971(2):197-209. DOI: 10.1016/s0006-8993(03)02361-8. View